medigraphic.com
ISSN 1561-3062 (Electronic)

2012, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2012; 38 (4)

Value of average pulsatility index of the uterine arteries in chronic hypertensive patients

Nodarse RA, Guzmán PR, Díaz GD

Language: Spanish
References: 23
Page:
PDF size: 63.37 Kb.


ABSTRACT

Introduction: patients with chronic hypertension have a frequency of 5 % to 25 % worsening of base hypertension during pregnancy, developing pre-eclampsia as more frequent event.
Objectives: to evaluate the application of Doppler flowmetry of the uterine arteries analyzing their average values as predictors of adverse perinatal outcomes.
Methods: an empirical, prospective, descriptive, non-interventionist study was conducted during a gestation moment. We studied 214 pregnant women attending Ramón González Coro OB/GYN hospital. These subjects had diagnosis of chronic hypertension from September 2007 to November 2010.
Results: 142 patients were younger than 35 years (66.4 %); 148 pregnant women had normal pulsatility index of the uterine arteries; 76.7 % had a newborn with appropriate weight for gestational age, and 28 showed relation to pre-eclampsia.
Conclusions: the characteristic age was under 35 was in this group studied. The sensitivity of the mean pulsatility index was good for intrauterine growth retardation (IUGR). This index showed the best value for the prediction of adverse perinatal outcomes.


REFERENCES

  1. Ferris,TF. Hipertension y preeclampsia. Complicaciones médicas durante el embarazo. Buenos Aires: Editorial Panamericana; 1996. p. 1-28.

  2. Sibai BM. Chronic hipertension in pregnancy. Clinic perinatol. 199;18:833-44.

  3. Pinedo A, Orderique L. Complicaciones materno peinatales de la preeclampsia eclampsia. Ginec y Obst. 2001;47(1 ):41-6.

  4. Gratacós E, Figueras F, Hernández E, Puerto B. Doppler en Medicina Fetal Barcelona: Editorial Médica Panamericana; 2010. p. 111-46.

  5. Gratacós E, Gómez R, Nicolaides K, Romero R, Cabero L. Medicina Fetal. Barcelona: Editorial Médica Panamericana; 2009. p. 631-658.

  6. Meads CA, Cnossen JS, Meher S. Methods of prediction and preventionof preeclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2008;12:1-270.

  7. Le Bouteiller P, Piccinni M. Human NK cells in pregnant uterus: Why there? Am J Reprod Immunol. 2008;59:401-6.

  8. Mable WC, Pernoll ML, Bismas MK. Chronic hypertension in pregnancy. Obstet Gynecol. 1986;67:197-205.

  9. Briceño-Pérez C, Briceño-Sanabria L. Conducta obstétrica basada en evidencias. Preeclampsia severa: ¿manejo agresivo o expectante? Ginecol Obstet Méx. 2007;75:95-103.

  10. Xiong X, Demianczuk NN, Saunders LD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol. 2002;155:203-9.

  11. Bombrys AE, Barton JR, Nowacki EA. Expectant management of severepreeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol. 2008;199:247e1-247 e6.

  12. Bujold E, Morency AM, Roberge S. Acetylsalicylic acid for the preventionof preeclampsia and intra-uterine growth restriction in women with abnormaluterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2009;31:818-26.

  13. Zimmermann P, Eirio BV , Koskinen j, Kujansuu E , Ranta T . Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnanacies at high risk for preclamapsia and-or intrauterine growth retardation: comparison and correlation between different Doppler parameters Ultrasound. Obstet Gynecol. 1997;9:330-8.

  14. Farré MT, Borrell A, Raveraw W, Azulay M, Cararach V, Fortuny A. Estudio Doppler de las arterias uterinas, predicción de complicaciones perinatales. Prog. Obstet Ginecol. 2001;44:537-43.

  15. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873-80.

  16. Sibai BM. Chronic hypertension in pregnancy. Clin Perinatal. 1999;18:4.

  17. Papageorghiou AT, Yu Ck, Bindra R, Pondis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriccion by Transvaginal uterine Doppler at 23 week· of gestation. Ultrasound Obstet Gynecol. 2001;18:441-9.

  18. Cabero l, Saldívar D, Cabrillo E. Obstetricia y Medicina Materno Fetal. Barcelona: Editorial Médica Panamericana; 2007.

  19. Khalil A, Cowans NJ, Spencer K. First trimester maternal serum placental protein 13 for the prediction of preeclampsia in women with a priori high risk. Prenat Diagn. 2009;29:781-9.

  20. Foidart JM,Munaut C, Chantraine F. Maternal plasma soluble endoglin at 1113 weeks' gestation in preeclampsia. Ultrasound Obstet Gynecol. 2010;35:680-7.

  21. Samolis S, Papastefanou I, Panagopoulos P. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and preeclamptic pregnancies: role of leptin as a marker of preeclampsia: a prospective case-control study. Gynecol Endocrinol. 2010;26:338-43.

  22. Poon LC, Kametas NA, Valencia C. Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 1113 weeks. Hypertens Pregnancy. 2011;30:93-107.

  23. David A, Amy M, Robert GL, Deborah E, Matthew C, Charlan K. Increased Preeclampsia in Mothers Delivering Very Low-Birth-Weight Infants between 1994 and 2006. Am J Perinatol. 2009;26:4672.




2020     |     www.medigraphic.com